BioCentury
ARTICLE | Financial News

Kalytera Therapeutics completes private placement

February 24, 2017 2:18 AM UTC

On Feb. 17, cannabinoid therapeutics company Kalytera Therapeutics Inc. (TSX-V:KALY) raised C$1.6 million ($1.2 million) through the sale of 3.5 million shares at C$0.45 in the second and final tranch...

BCIQ Company Profiles

Claritas Pharmaceuticals Inc.